Search Research Articles
Browse Research Categories

Pancragen Peptide Research

Pancragen is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) derived from pancreatic tissue, developed as part of the organ-specific bioregulator research program of the St. Petersburg Institute of Bioregulation and Gerontology. Studies have explored its targeted regulatory effects on pancreatic acinar and islet cells, with research investigating its potential to normalize pancreatic gene expression, support insulin secretion mechanisms, and protect against age-related and stress-induced pancreatic decline. Research has also examined its potential relevance to diabetes management and metabolic regulation. This section covers scientific studies on Pancragen and its pancreatic tissue bioregulator and metabolic research applications.

Other Popular Research Categories

Newest Pancragen Research

Pancragen Peptide Research – Complete Guide

Pancragen, also known by its amino acid sequence KEDW, is a synthetic tetrapeptide bioregulator derived from bovine pancreatic tissue and studied for its effects on pancreatic cell differentiation, glucose metabolism, and epigenetic gene regulation. Research conducted primarily at Russian and European institutions over more than two decades suggests the peptide may influence transcription factors governing pancreatic development and modulate insulin...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0